Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial)
about
sameAs
Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromesPlatelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromesPlatelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromesPlatelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarctionClopidogrel in acute coronary heart diseaseElevated cardiac troponin I in sepsis and septic shock: no evidence for thrombus associated myocardial necrosisTirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials.The Role of Glycoprotein IIb/IIIa Inhibitors- A Promise Not Kept?Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis.Routine early versus deferred provisional tirofiban treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention.Effects of clopidogrel, prasugrel and ticagrelor on endothelial function, inflammatory and oxidative stress parameters and platelet function in patients undergoing coronary artery stenting for an acute coronary syndrome. A randomised, prospective, cRole of cardiac troponin testing in percutaneous transluminal coronary angioplasty.Tirofiban in acute coronary syndromes.Peri-procedural myocardial injury: 2005 update.2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and InterventiEffects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT-ACS Trial.Tirofiban: a critical reappraisal of the clinical use, recent developments and future perspectives.Baseline troponin level: key to understanding the importance of post-PCI troponin elevations.The assessment of Shin's method for the prediction of creatinine kinase-MB elevation after percutaneous coronary intervention: an intravascular ultrasound study.
P2860
Q24202522-E3FC9616-483B-43D9-BF62-3C2920BA323AQ24202999-97AD29CD-4026-4396-8AF6-093C96790C15Q24235385-C77955BD-CFE1-46A6-9C2A-86B12A7DD495Q28191096-BDFDD69E-2FF4-4DB5-BD84-565A85C240C1Q28193776-C440C88F-21CC-4C9A-BEF9-50714A972720Q28749111-E9A4DF59-6052-42EC-BE3F-FBCF25AD01E3Q33386229-6F515228-DB81-4CE1-A7A5-19E93DFA2122Q33387192-6C264719-E577-4762-850F-2DAB6EF97880Q33390176-0FB32FB2-FCB3-4786-A7BF-15981372E7EDQ33406801-DE6D3A67-9266-4BA0-AF0A-0CA096D231ADQ33629248-52A5FF56-3DE0-48AE-AAF2-F93275DA3E65Q35158845-A9944355-A6A0-4BD1-BAEF-C4EB3107EA45Q36107187-986A68AB-260B-4DD1-A84E-B579816A5A89Q36263844-8682A792-67F6-47E8-A8DF-72B078C1D2CFQ37953885-0AE30B1F-063D-436D-87C8-1E5F0CD35845Q38384596-C5FE3D17-2A90-4605-897B-A06A79C0A41FQ40361591-32622DB5-D1D5-4205-B172-41AEAD76E78EQ46947043-0D9AEA9F-F061-444E-8376-292D25AD983EQ54639264-D9F06B79-C109-44D4-9CA8-CB6B361F46DE
P2860
Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial)
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Effect of additional temporary ...... nd clopidogrel (TOPSTAR trial)
@ast
Effect of additional temporary ...... nd clopidogrel (TOPSTAR trial)
@en
Effect of additional temporary ...... nd clopidogrel (TOPSTAR trial)
@nl
type
label
Effect of additional temporary ...... nd clopidogrel (TOPSTAR trial)
@ast
Effect of additional temporary ...... nd clopidogrel (TOPSTAR trial)
@en
Effect of additional temporary ...... nd clopidogrel (TOPSTAR trial)
@nl
prefLabel
Effect of additional temporary ...... nd clopidogrel (TOPSTAR trial)
@ast
Effect of additional temporary ...... nd clopidogrel (TOPSTAR trial)
@en
Effect of additional temporary ...... nd clopidogrel (TOPSTAR trial)
@nl
P2093
P1476
Effect of additional temporary ...... nd clopidogrel (TOPSTAR trial)
@en
P2093
Andreas W Bonz
Björn Lengenfelder
Christian Wacker
Christiane Waller
Georg Ertl
Jörg Strotmann
Kerstin Harre
Ludwig Neyses
Malte Meesmann
Nikolaus Kochsiek
P356
10.1016/S0735-1097(02)02014-4
P407
P577
2002-08-21T00:00:00Z